Developing E-liquid Product Standards (Sweet Spot Study)

Last updated: March 21, 2025
Sponsor: Ohio State University Comprehensive Cancer Center
Overall Status: Completed

Phase

N/A

Condition

N/A

Treatment

Vaping study EC C

Vaping study EC A

Vaping study EC G

Clinical Study ID

NCT05864586
OSU-22253
NCI-2023-03206
  • Ages 21-50
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The Sweet Spot Study aims to evaluate the effect of e-liquids with nicotine varying in freebase (FB) levels and concentrations on the appeal of electronic cigarettes (ECs) in young adult EC users with minimal/no history of smoking and older adult smokers.

Eligibility Criteria

Inclusion

Inclusion criteria:

  1. Young adult e-cigarette user or older adult smoker

  2. Willing to abstain from all nicotine product use for 12 hours prior to the studyvisit

  3. Read and speak English

Exclusion

Exclusion criteria:

  1. Currently attempting to quit nicotine products

  2. Currently pregnant, planning to become pregnant, or breastfeeding

  3. Current or past use of tobacco products other than e-cigarettes or cigarettes

  4. Self-reported diagnosis of lung disease

  5. Self-reported new or unstable cardiovascular disease

Study Design

Total Participants: 150
Treatment Group(s): 10
Primary Treatment: Vaping study EC C
Phase:
Study Start date:
May 30, 2023
Estimated Completion Date:
February 26, 2024

Connect with a study center

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio 43210
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.